QUELL THERAPEUTICS

quell-therapeutics-logo

Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions. Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto S... anchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.

#SimilarOrganizations #People #Financial #Website #More

QUELL THERAPEUTICS

Social Links:

Industry:
Association Biotechnology Education Health Care

Founded:
2019-03-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.quell-tx.com

Total Employee:
101+

Status:
Active

Total Funding:
240.55 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Content Delivery Network Nginx Euro Microsoft Exchange Online


Similar Organizations

emendo-biotherapeutics-logo

Emendo Biotherapeutics

Emendo Biotherapeutics is a biotechnology company

caraway-therapeutics-logo

Caraway Therapeutics

Rheostat Therapeutics is a bio therapeutics company.


Current Advisors List

houman-ashrafian_image

Houman Ashrafian Board Member @ Quell Therapeutics
Board_member
2021-11-01

barny-cox_image

Barny Cox Board Member @ Quell Therapeutics
Board_member

jeffrey-long-mcgie_image

Jeffrey Long-McGie Board Member @ Quell Therapeutics
Board_member
2021-11-01

not_available_image

Rachel Mears Board Member @ Quell Therapeutics
Board_member
2021-11-01

Current Employees Featured

iain-mcgill_image

Iain McGill
Iain McGill CEO @ Quell Therapeutics
CEO

marc-martinez-llordella_image

Marc Martinez-Llordella
Marc Martinez-Llordella Co-founder & VP Biology @ Quell Therapeutics
Co-founder & VP Biology
2019-10-01

not_available_image

Alberto Sanchez-Fueyo
Alberto Sanchez-Fueyo Founder & Non-Executive Director @ Quell Therapeutics
Founder & Non-Executive Director

giovanna-lombardi_image

Giovanna Lombardi
Giovanna Lombardi Founder @ Quell Therapeutics
Founder

not_available_image

Hans Stauss
Hans Stauss Founder @ Quell Therapeutics
Founder

Founder


not_available_image

Alberto Sanchez-Fueyo

giovanna-lombardi_image

Giovanna Lombardi

not_available_image

Hans Stauss

marc-martinez-llordella_image

Marc Martinez-Llordella

Investors List

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Series B - Quell Therapeutics

jeito-capital_image

Jeito Capital

Jeito Capital investment in Series B - Quell Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - Quell Therapeutics

point72_image

Point72

Point72 investment in Series B - Quell Therapeutics

syncona-partners-llp_image

Syncona Partners LLP

Syncona Partners LLP investment in Series B - Quell Therapeutics

british-patient-capital_image

British Patient Capital

British Patient Capital investment in Series B - Quell Therapeutics

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series B - Quell Therapeutics

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - Quell Therapeutics

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series B - Quell Therapeutics

monashee-investment_image

Monashee Investment Management

Monashee Investment Management investment in Series B - Quell Therapeutics

Official Site Inspections

http://www.quell-tx.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.02 K

  • Host name: 213.14.214.35.bc.googleusercontent.com
  • IP address: 35.214.14.213
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Quell Therapeutics" on Search Engine